Meta Pixel

News and Announcements

Folkestone Outperforms Benchmark by 4.62%.

  • Published April 13, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

For the 12 months to March 2017, the Fund returned +10.93% (after Fees but Before Tax), outperforming its benchmark by 4.62%.

The Monthly Report provides a snapshot of the Fund and the A-REIT sector’s performance.

Market Review

During March, the US Federal Reserve carried out one of the three anticipated Federal Fund rate hikes for 2017, taking the cash rate 25 basis points higher to a range of 0.75-1.00%. The outlook however, was perceived to be ‘dovish’ and generated concerns about the US economy going into a period of reflation.

Request Information 

Full Report 

Capital Insights
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be  Attracting Big Pharma’s Attention

Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Join over 45,000+ sophisticated investors

Join Now